Mkts

ImmuCell Corporation

NASDAQ: ICCC
$11.25-0.08 (-0.71%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
11.0211.35
52-week range
4.5212.10
Today
Open11.31
Previous close11.25
Volume4.2K
Valuation
Market cap103.87M
P/E ratio131.92×
EPS (TTM)0.08
Income & risk
Dividend / yield—
Beta0.59
Avg volume19.1K
Discussion

ICCC News

Stories mentioning ICCC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue10,3577,6265,5066,4458,0677,7506,0125,473
Cost of Goods Sold5,7004,7163,1433,6274,7134,9204,4284,242
Gross Profit4,6572,9102,3632,8183,3542,8321,5841,230
Operating Expenses
Research & Development318.00759.00694.00832.00757.00819.00786.001,031
Sales General & Admin
Total Operating Expenses2,6882,9692,3432,2482,2362,2112,1582,617
Operating Income (Loss)1,969(59.00)20.00570.001,118622.00(575.00)(1,387)
Interest Income44.0041.0037.0019.00
Interest Expense144.00142.00
Other Expense(125.00)(144.00)
Pretax Income1,954(2,846)(135.00)504.001,449520.00(700.00)(1,530)
Tax Provision13.004.004.002.002.007.001.001.00
Net Income (Loss)1,942(2,849)(140.00)502.001,447515.00(702.00)(1,532)
Earnings Per Share (Basic)0.21(0.32)(0.02)0.060.160.06(0.09)(0.20)
Earnings Per Share (Diluted)0.21(0.32)(0.02)0.060.160.06(0.09)(0.20)
Weighted Average Shares Outstanding (Basic)9,0469,0269,0469,0318,9818,1678,1647,810
Weighted Average Shares Outstanding (Diluted)9,0469,0269,0469,0318,9818,1678,1647,810

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ICCC

ImmuCell Corporation (NASDAQ: ICCC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ICCC. It last traded at $11.25 (Nov 18, 2026, 4:00 PM ET), down 0.7% on the day. That gives ImmuCell a market capitalisation of $103.9M and a price-to-earnings ratio of 131.9.

Over the past 52 weeks ICCC has traded between $4.52 and $12.10.

Revenue for the quarter ended Mar 31, 2026 was $10.4M; net income $1.9M. Revenue was up 28.4% from $8.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$10.4M$1.9M18.8%
Dec 31, 2025$7.6M-$2.8M-37.4%
Sep 30, 2025$5.5M-$140.0K-2.5%
Jun 30, 2025$6.4M$502.0K7.8%

From ImmuCell’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…